Original InvestigationsComorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE study☆,☆☆,★
Section snippets
Study design and patient eligibility
We conducted a cross-sectional analysis of baseline data on incident dialysis patients recruited from 81 dialysis units in 19 states of the US participating in the CHOICE Cohort Study. Patients were eligible if they had started chronic outpatient dialysis during the 3 months before enrollment, were 18 years or older, spoke English or Spanish, and gave informed consent. Home HD and hospice patients were excluded.
Patients were recruited from 79 dialysis units associated with Dialysis Clinic, Inc
Recruitment
Approximately two-thirds of eligible patients were enrolled from the participating dialysis units. Eligible patients enrolled were similar to eligible patients not enrolled with regard to gender and age. A total of 1,041 incident dialysis outpatients were enrolled from 81 dialysis centers; 279 PD dialysis (27%) and 762 HD patients (73%). Three HD patients did not have a completed ICED at baseline and were excluded from analyses in this report. Nine hundred and twenty-one patients (89%) were
Discussion
Within the US there is significant variation in PD utilization. Factors responsible for variation are not completely understood, but may include patients' clinical characteristics, medical judgement, physicians' and patients' preferences, and differences in physician and facility reimbursement.24 A detailed characterization of differences in PD versus HD patients in the present study shows the extent by which these patient groups differ at the onset of chronic dialysis therapy.
We observed fewer
Acknowledgements
We thank the patients, staff, and physicians who participated in the CHOICE Study at Dialysis Clinic, Inc, St. Raphael's Hospital and New Haven CAPD. We also acknowledge and thank the CHOICE-DCI Clinical Liaison Committee (Thomas Depner, MD, H. Keith Johnson, MD, K Shashi Kant, MD, Klemens Meyer, MD, Richard Sherman, MD, Edward Schroeder, MD, Pradip Teredesai, MD, John Van Stone, MD, and Philip Zager, MD) and the New Haven CAPD Clinical Liaison Committee (Frederic Finkelstein, MD and Alan
References (34)
- et al.
Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions
Kidney Int
(1994) - et al.
Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
Am J Kidney Dis
(1990) - et al.
Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis
Am J Kidney Dis
(1994) - et al.
Urea index and other predictors of hemodialysis patient survival
Am J Kidney Dis
(1994) - et al.
The dose of hemodialysis and patient mortality
Kidney Int
(1996) - et al.
Mortality risks of peritoneal dialysis and hemodialysis
Am J Kidney Dis
(1999) - et al.
Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates
Am J Kidney Dis
(1997) - et al.
Comparative mortality of hemodialysis and peritoneal dialysis in Canada
Kidney Int
(2000) The pre-therapeutic classification of comorbidity in chronic disease
J Chron Dis
(1970)- et al.
Comorbidity assessment using the Index of Coexistent Diseases (ICED) in a multicenter clinical trial: The Hemodialysis (HEMO) Study
Kidney Int
(2001)
Functional status and quality of life: Predictors of early mortality among patients entering treatment for end-stage renal disease
J Clin Epidemiol
Mechanisms of hypoalbuminemia in hemodialysis patients
Kidney Int
The impact of comorbid risk factors at the start of dialysis upon the survival of ESRD patients
ASAIO J
The Index of Coexistent Disease (ICED) is an independent predictor of death in a prospective ESRD cohort
J Am Soc Nephrol
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
N Engl J Med
Risk factors for hospital utilization in chronic dialysis patients
J Am Soc Nephrol
US Renal Data System: Excerpts From the USRDS 1999 Annual Data Report
Am J Kidney Dis
Cited by (144)
Physical Resilience Phenotype Trajectories in Incident Hemodialysis: Characterization and Mortality Risk Assessment
2022, Kidney International ReportsCitation Excerpt :Body mass index (in kg/m2) was based on height and weight reported on the Health Care Financing Administration Medical Evidence Report (HCFA Form 2728).17 Kidney disease specific markers selected included the following: (i) type of vascular access, by category: arteriovenous fistula or graft, or central venous catheter or unknown;25 (ii) predialysis initiation nephrology consult timing (early [>12 months], intermediate [4–12 months], late [<4 months], unclassified, or missing)26; (iii) laboratory values for serum albumin (g/dl) obtained from HCFA Form 2728;27 and (iv) estimated glomerular filtration rate, calculated using the 4-variable Modification of Diet in Renal Disease Study equation.28 We modeled comorbidities using the Index of Coexistent Disease (ICED), a validated index of presence and severity of comorbid conditions used extensively in mortality risk prediction in patients with kidney failure.
Cohort Study of Outpatient Hemodialysis Management Strategies for COVID-19 in North-West London
2020, Kidney International ReportsThe Role of the Chronic Kidney Disease Clinic and Multidisciplinary Team Care
2018, Chronic Kidney Disease, Dialysis, and Transplantation: A Companion to Brenner and Rector’s The KidneyFactors affecting the choice of peritoneal dialysis: Perspective of patients and nephrologists
2017, Nephrologie et Therapeutique
- ☆
Supported in part by a grant from the Agency for Healthcare Research and Quality (AHRQ) (formerly Agency for Health Care Policy Research [AHCPR] HS08365 to N.R.P.) and a Clinical Research Fellowship from the Alberta Heritage Foundation for Medical Research (to D.C.M.).
- ☆☆
Address reprint requests to Andrew S. Levey, MD, New England Medical Center, Division of Nephrology, Box 391, Boston, MA 02111. E-mail: [email protected]
- ★
0272-6386/02/3902-0011$35.00/0